Selvita - millions from WSE to fight cancer

January - December 2014

Selvita - millions from WSE to fight cancer

Awarded with the 2015 Golden Clip award, an annual educational and promotional campaign associated with the Public Offering of Shares and IPO unique in WSE. In less than a year, we implemented a number of measures aimed at institutional and individual investors, using innovative communication channels and engaging internationally recognized experts in the areas of analysis and valuation of companies in the biotechnology sector.

Initial situation

Selvita is a biotechnology company founded in 2007 by former top managers of the listed Comarch. Despite the lack of experience in biotechnology, in a few years they built an organization that teamed up with major pharmaceutical concerns in the world. In 2011 Selvita debuted on the NewConnect market, acquiring from a private placement the amount of PLN 14.9 million. After the placement, the company focused on the development of business and did not carry out active communication with the media and the financial market. As a result, the market position and financial results of Selvita significantly increased,
but its value on the stock exchange within two years fell by more than half.
Recognition of the Company was small and journalists and investors did not understand the business model. On the Stock Exchange there were no comparable companies and classic valuation methods and indicators did not apply. Reactions of investors to the breakthrough information, from the point of view of Selvita, were not satisfactory.


InnerValue task was to build awareness of the Company and conduct educational activities, leading to a better understanding of both the business model of Selvita and the methods of valuation of biotech companies. This was aimed at supporting the Company's planned issue of shares and transfer of listing from NewConnect to the main floor of the Warsaw Stock Exchange.

Action taken

InnerValue took temporary measures, such as establishing relationships with representatives of the major media and the organization of meetings in the formula of non-deal roadshow, the aim of which was to analyze the perception of the Company and its business model. Furthermore, together with the Company the comprehensive, long-term communication strategy divided into three stages was developed.

Phase I (I-VII 2014) - explanation of the Selvita business model, the characteristics of the global biotechnology market and the basis of the valuation of the companies in this sector:

Relations with media
Study tour for investors and analysts to laboratories of Selvita in Cracow
Two educational meetings - for investors and analysts and individual investors - in Warsaw

Phase II (XI 2014) - education in the field of advanced methods of analysis and valuation of biotech companies:

Start of cooperation with Edison Investment Research - a global analysing office covering, among others, approx. 150 biotechnology companies around the world. Analytical Report on Selvita
Several hour-long educational seminar at the headquarters of the Warsaw Stock Exchange, which was attended by Ralph Villiger - internationally recognized expert, author of books on valuations of biotech companies - and Christian Glennie - author of Edison analytical reports on Selvita

Phase III (XII 2014) - comprehensive promotional campaign of the Public Offering of Shares:

A broad online campaign divided into direct (on-line broadcast, LiveChat tool on the Selvita website, investor chat with the Board) and indirect communication (corporate film, intense banner campaign, re-marketing, promotion in social media)
Active communication with the media and investors


During the campaign Selvita reached directly more than 100 institutional and individual investors. Completed actions helped to generate unprecedented interest in the Offering. Investors - expecting high reduction made in the Offer subscriptions - even during the subscriptions were buying shares of the company listed on NewConnect even 20 percent more expensive than the maximum price in the Offer.
Selvita acquired in the offer PLN 27.3 million selling shares at the maximum price, which made it possible to acquire sufficient funds for the implementation of the strategy. Individual investors made subscriptions worth more than eight times the number of shares offered (the reduction was 88 percent). The largest Polish pension and investment funds became the shareholders.

The project was awarded the 2015 Golden Clip for the best campaign in the Financial PR and Investor Relations.

Selvita SA continues to cooperate with InnerValue

Other Case studies

So we act

see all

Trans Polonia – nearly PLN 50 mln for further expansion of the biggest tanker truck fleet in Poland

Our relationship begun at a breakthrough moment in the thirteen-year history of Trans Polonia (TPG) - the company has just acquired Orlen Transport, becoming the domestic leader in the logistics shipments of vehicle and aviation fuel, as well as LNG. This exponential increase in the scale of operations has prompted TPG to open up to institutional investors - a visible boost in the level of interest and improved sentiment have convinced TPG to reach for another milestone - an investment program for the years 2018-2020, to be financed largely via a secondary public offering. InnerValue has assisted the company in that process, which concluded successfully with the raising of PLN 49.3 mln in new equity.


Mercator Medical – intense and effective campaign in support of SPO

Scheduled for two months information campaign aimed at institutional and individual investors. Effective communication, the main axis of which was the update of the strategy of the company, helped in the short term to raise the valuation of the shares by more than 25% and guaranteed the success of a secondary public offering of Mercator Medical worth PLN 31.5 million


Energa – communication related to IPO and debut on the Warsaw Stock Exchange

In the fourth quarter of 2013 Energa SA carried out one of the largest in recent years - worth PLN 2.4 billion - public offering and was listed on the Warsaw Stock Exchange. Implementation of an extensive communication plan allowed the achievement of viral interest in the offer. The IPO of Energa SA was attended by 72 thousand individual investors, nearly 1/4 of all active investors on the Warsaw Stock Exchange in 2013.


NEUCA - common values, common goals

The cooperation of InnerValue with NEUCA, the company entering mWIG40 index, began in 2011 and includes comprehensive services in the field of investor relations. The activities carried out include modern forms of communication, such as eg. video-content. Within five years of cooperation, the company's share price rose by almost 600%, while the dynamics of the results was approx. three times lower.


Enea - long-term, comprehensive service of the Company

ENEA SA manages the Capital Group which belongs to the group of the largest Polish energy companies. From November 2010 to January 2018 InnerValue agency has conducted for the Company the comprehensive range of investor relations measures directed to specific audiences: fund managers, financial analysts, shareholders and individual investors.


LiveChat Software - Polish investors, American pricing

IPO awarded with the 2014 Golden Clip 2014. The most important challenge was the lack of comparable listed companies. The value of the Public Offering amounted to almost PLN 60 million. The company debuted on the WSE main market and was valued at PLN 476 million at an exceptionally high rate of price / earnings (P / E) of 48,6x.


CD Projekt - from Optimus to CD Projekt

CD Projekt RED entered the Warsaw Stock Exchange as a result of a reverse takeover by already listed Optimus. In practice, therefore, the shareholders of CD Projekt RED took control of Optimus, which at the time the transaction was not operating and did not have a good reputation among investors. The most important challenge InnerValue had to face was to build a positive image of the company on the capital market.